A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[¹⁸F]fluoro-2-deoxy-d-galactose

References

• Andres A, Majno PE, Morel P, et al. Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score. Ann Surg Oncol. 2008;15:134–143.
   PubMed Web of Science ®Google Scholar
• Donadon M, Solbiati L, Dawson L, et al. Hepatocellular carcinoma: the role of interventional oncology. Liver Cancer. 2016;6:34–43.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917.
   PubMed Web of Science ®Google Scholar
• Hoyer M, Swaminath A, Bydder S, et al. Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys. 2012;82:1047–1057.
   PubMed Web of Science ®Google Scholar
• Mendez Romero A, Wunderink W, Hussain SM, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i-ii study. Acta Oncol. 2006;45:831–837.
   PubMed Web of Science ®Google Scholar
• Hoyer M, Roed H, Traberg Hansen A, et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol. 2006;45:823–830.
   PubMed Web of Science ®Google Scholar
• Tree AC, Khoo VS, Eeles RA, et al. Stereotactic body radiotherapy for oligometastases. Lancet Oncol. 2013;14:e28–e37.
   PubMed Web of Science ®Google Scholar
• Fode MM, Hoyer M. Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases. Radiother Oncol. 2015;114:155–160.
   PubMed Web of Science ®Google Scholar
• Pan CC, Kavanagh BD, Dawson LA, et al. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010;76:S94–S100.
   PubMed Web of Science ®Google Scholar
• Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys. 2000;47:551–560.
   PubMed Web of Science ®Google Scholar
• Partridge M, Yamamoto T, Grau C, et al. Imaging of normal lung, liver and parotid gland function for radiotherapy. Acta Oncol. 2010;49:997–1011.
   PubMed Web of Science ®Google Scholar
• Sorensen M, Munk OL, Mortensen FV, et al. Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography. Am J Physiol Gastrointest Liver Physiol. 2008;295:G27–G36.
   PubMed Web of Science ®Google Scholar
• Sorensen M, Mikkelsen KS, Frisch K, et al. Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-d-galactose PET/CT. J Nucl Med. 2011;52:1566–1572.
   PubMed Web of Science ®Google Scholar
• Fode MM, Petersen JB, Sørensen M, et al. 18F]fluoro-2-deoxy-d-galactose positron emission tomography guided functional treatment planning of stereotactic body radiotherapy of liver tumours. Phys Imag Radiat Oncol. 2017;1:28–33.
   Google Scholar
• Poulsen PR, Worm ES, Hansen R, et al. Respiratory gating based on internal electromagnetic motion monitoring during stereotactic liver radiation therapy: first results. Acta Oncol. 2015;54:1445–1452.
   PubMed Web of Science ®Google Scholar
• Buus S, Grau C, Munk OL, et al. Individual radiation response of parotid glands investigated by dynamic 11C-methionine PET. Radiother Oncol. 2006;78:262–269.
   PubMed Web of Science ®Google Scholar
• Kirkwood B, Sterne J. Medical statistics. Malden (MA): Blackwell Science; 2007.
   Google Scholar
• Lavrenkov K, Christian JA, Partridge M, et al. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Radiother Oncol. 2007;83:156–162.
   PubMed Web of Science ®Google Scholar
• Bowen SR, Saini J, Chapman TR, et al. Differential hepatic avoidance radiation therapy: proof of concept in hepatocellular carcinoma patients. Radiother Oncol. 2015;115:203–210.
   PubMed Web of Science ®Google Scholar
• Duprez F, De Neve W, De Gersem W, et al. Adaptive dose painting by numbers for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011;80:1045–1055.
   PubMed Web of Science ®Google Scholar
• Rasmussen JH, Hakansson K, Vogelius IR, et al. Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer. Radiother Oncol. 2016;120:76–80.
   PubMed Web of Science ®Google Scholar
• De Bari B, Jumeau R, Deantonio L, et al. Role of functional imaging in treatment plan optimization of stereotactic body radiation therapy for liver cancer. Tumori. 2016;102:e21?e24.
   PubMed Web of Science ®Google Scholar
• Brade AM, Ng S, Brierley J, et al. Phase 1 Trial of Sorafenib and stereotactic body radiation therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2016;94:580–587.
   PubMed Web of Science ®Google Scholar
• Petersen JB, Lassen Y, Hansen AT, et al. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours. Acta Oncol. 2011;50:823–828.
   PubMed Web of Science ®Google Scholar
• Petersen JB, Fode MM, Worm ES, et al. FDGal guided functional treatment planning for liver SBRT using scanning proton beams. Abstract PTCOG. PTCOG55, O 69, 2016.
   Google Scholar
• Howells CC, Stinauer MA, Diot Q, et al. Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases. Int J Radiat Oncol Biol Phys. 2012;84:e441–e446.
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang H, Johnson TD, et al. Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging. Int J Radiat Oncol Biol Phys. 2013;85:258–263.
   PubMed Web of Science ®Google Scholar
• Kwon YJ, Lee KG, Choi D. Clinical implications of advances in liver regeneration. Clin Mol Hepatol. 2015;21:7–13.
   PubMed Web of Science ®Google Scholar
• Cao Y, Pan C, Balter JM, et al. Liver function after irradiation based on computed tomographic portal vein perfusion imaging. Int J Radiat Oncol Biol Phys. 2008;70:154–160.
   PubMed Web of Science ®Google Scholar
• Dawson LA, Normolle D, Balter JM, et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53:810–821.
   PubMed Web of Science ®Google Scholar